Thursday, July 9, 2026

Drug profile · INN

sodium thiosulfate

sodium thiosulfate (PEDMARQSI) is a unknown. Associated with FENNEC PHARMACEUTICALS INC.. Route of administration: injection. Current US regulatory status: approved.

FDA: approved EMA: approved
US status approved
Patents linked 8
Pipeline programs 3
News articles 0
Drug details — sodium thiosulfate
US status
approved
Class
Route
INJECTION
Patents
8
Programs
3
Data quality
0.89

Quick answer

sodium thiosulfate (PEDMARQSI) is a unknown. Associated with FENNEC PHARMACEUTICALS INC.. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN sodium thiosulfate
Brand PEDMARQSI
Mechanism Unknown
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Unknown

Approval history

Authority Status Date
FDA approved
EMA approved

Pipeline programs

  1. Sodium Thiosulfate Injection Phase 3 · Shanghai University of · Hepatoblastoma
  2. Pedmark® STS Phase 2 · FENNEC PHARMACEUTICALS · Solid Tumor Malignancies
  3. ARQ 197 Phase 1 · Kyowa Kirin International · Advanced Hepatocellular Carcinoma
  1. US 12311026

    Therapeutic uses for sodium thiosulfate formulations

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 11998604

    Therapeutic uses for sodium thiosulfate formulations

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 11992530

    Therapeutic uses for sodium thiosulfate and formulations

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 11964018

    Therapeutic uses for sodium thiosulfate formulations

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 11617793

    Anhydrous sodium thiosulfate and formulations thereof

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 11510984

    Anhydrous sodium thiosulfate and formulations thereof

    Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 11291728

    Anhydrous sodium thiosulfate and formulations thereof

    Expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 10792363

    Anhydrous sodium thiosulfate and formulations thereof

    Expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is sodium thiosulfate?

sodium thiosulfate (PEDMARQSI) is a unknown. Associated with FENNEC PHARMACEUTICALS INC.. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for sodium thiosulfate?

PEDMARQSI is a marketed brand name for sodium thiosulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sodium thiosulfate?

sodium thiosulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.